Xiaolin Xu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Xiaolin Xu has a total of 35 co-authors. Here are the top co-authors by number of shared publications:
- Wen Bin Wei
Beijing Tongren Eye Center, Beijing key Laboratory of Intraocular Tumor Diagnosis and Treatment, Beijing Ophthalmology&Visual Sciences Key Lab, Medical Artificial Intelligence Research and Verification Key Laboratory of the Ministry of Industry and Information Technology, Beijing Tongren Hospital, Capital Medical University, Beijing, China
6 shared publications Yueming Liu
Beijing Tongren Eye Centre, Beijing Tongren Hospital, Beijing, China
3 shared publications- Fei Gao
Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing 100029, China
2 shared publications - Jost Bruno Jonas
Rothschild Foundation Hospital, Paris, France
2 shared publications Liaoqing Li
Beijing Institute of Ophthalmology, Beijing TongRen Hospital, Capital Medical University, Beijing, PR China
2 shared publicationsNan Zhou
Being Tongren Hospital
2 shared publications
Latest Publications
- Open Access
- 7 December 2025
- Published by BMJ in British Journal of Ophthalmology
- Vol. 110 (5) , 592-600
Histopathological characteristics of secondary enucleation after iodide-125 plaque radiotherapy in Chinese patients with uveal melanoma
Purpose To explore the histopathological characteristics in eyes with uveal melanoma (UM) that had secondary enucleation after iodine-125 plaque radiotherapy (PRT). Methods This study included 243 patients with unilateral UM treated at Beijing Tongren Hospital from 2007 to 2020. Of these, 119 initially received PRT, followed by enucleation 2 months–9 years later. We retrospectively examined the histopathological features of enucleated ocular tissues to investigate microscopic differences based on treatment methods and reasons for secondary enucleation. Results Compared with 124 primary enucleations, eyes after PRT were more likely to show tumour diffuse distribution; had more tumour cell necrosis and more inflammation. In addition, eyes after PRT had a higher frequency of sclera invasion, optic nerve invasion by the tumour and neovascularisation of the iris. Histopathologically, 55 eyes (46%) were removed due to local control failure. Compared with eyes enucleated because of severe radiotherapy complications, eyes enucleated for local control failure had tumours invading the optic disc and ciliary body more frequently, pathological mitosis and the proportion of tumour diffuse distribution were higher. Eyes with radiotherapy complications had more tumour tissue necrosis and more neovascularisation of the iris. Conclusions By observing the pathological features, we regrouped the patients who underwent secondary enucleation after PRT. These differences in histopathology may represent tissue effects of radiotherapy radiation or features related to tumour progression and growth. Tumour insensitivity and progression after PRT clearly increased the risk of metastasis-related death. Some pathological microscopic features may be important prognostic indicators of patients with UM.
- 7 December 2025
- Published by BMJ in British Journal of Ophthalmology
- Vol. 110 (5) , 592-600
Open AccessHistopathological characteristics of secondary enucleation after iodide-125 plaque radiotherapy in Chinese patients with uveal melanoma
Purpose To explore the histopathological characteristics in eyes with uveal melanoma (UM) that had secondary enucleation after iodine-125 plaque radiotherapy (PRT). Methods This study included 243 patients with unilateral UM treated at Beijing Tongren Hospital from 2007 to 2020. Of these, 119 initially received PRT, followed by enucleation 2 months–9 years later. We retrospectively examined the histopathological features of enucleated ocular tissues to investigate microscopic differences based on treatment methods and reasons for secondary enucleation. Results Compared with 124 primary enucleations, eyes after PRT were more likely to show tumour diffuse distribution; had more tumour cell necrosis and more inflammation. In addition, eyes after PRT had a higher frequency of sclera invasion, optic nerve invasion by the tumour and neovascularisation of the iris. Histopathologically, 55 eyes (46%) were removed due to local control failure. Compared with eyes enucleated because of severe radiotherapy complications, eyes enucleated for local control failure had tumours invading the optic disc and ciliary body more frequently, pathological mitosis and the proportion of tumour diffuse distribution were higher. Eyes with radiotherapy complications had more tumour tissue necrosis and more neovascularisation of the iris. Conclusions By observing the pathological features, we regrouped the patients who underwent secondary enucleation after PRT. These differences in histopathology may represent tissue effects of radiotherapy radiation or features related to tumour progression and growth. Tumour insensitivity and progression after PRT clearly increased the risk of metastasis-related death. Some pathological microscopic features may be important prognostic indicators of patients with UM.
- 2 January 2024
- Published by Springer Nature in Eye
- Vol. 38 (7) , 1314-1319
Intraocular schwannoma: case series of 28 patients and literature review
Purpose Intraocular schwannoma is a rare tumour, which is often misdiagnosed. We presented the demographics and clinical characteristics of patients with intraocular schwannoma. Methods Retrospective case series were collected between May 2005 and July 2021 in Beijing Tongren Hospital. Results A total of 28 patients were diagnosed with intraocular schwannoma on histopathological examination of surgical specimen. The median age was 39 years (range: 12–64). Fourteen patients were female and 14 were male. Among the all subjects, 21/28 patients (75.0%) presented as visual loss, and 3/28 patients (10.7%) had visual field loss. Intraocular schwannoma presented as nonpigmented mass in the ciliary body in 12/28 cases (42.9%), in the choroid in 9/28 cases (32.1%), and in ciliochoroid in 7/28 cases (25.0%). Intraocular schwannoma was often clinically misdiagnosed as uveal melanoma, which occurred in 16/28 patients (57.1%). Tumour excision with pars plana vitrectomy was performed for all included patients. Endoresection with lens removal was performed for tumours in the choroid, while transscleral resection was performed for tumours located in ciliary body or ciliochoroid. Increased light transmission was detected in 12/28 cases (42.9%). In the consecutive follow-up (median: 73 months, range: 7–193 months), no cases of recurrence or metastatic disease were detected. Conclusions Intraocular schwannoma is a rare benign tumour. It usually presents as nonpigmented mass, which can easily be misdiagnosed as nonpigmented uveal melanoma.
- 2 January 2024
- Published by Springer Nature in Eye
- Vol. 38 (7) , 1314-1319
Intraocular schwannoma: case series of 28 patients and literature review
Purpose Intraocular schwannoma is a rare tumour, which is often misdiagnosed. We presented the demographics and clinical characteristics of patients with intraocular schwannoma. Methods Retrospective case series were collected between May 2005 and July 2021 in Beijing Tongren Hospital. Results A total of 28 patients were diagnosed with intraocular schwannoma on histopathological examination of surgical specimen. The median age was 39 years (range: 12–64). Fourteen patients were female and 14 were male. Among the all subjects, 21/28 patients (75.0%) presented as visual loss, and 3/28 patients (10.7%) had visual field loss. Intraocular schwannoma presented as nonpigmented mass in the ciliary body in 12/28 cases (42.9%), in the choroid in 9/28 cases (32.1%), and in ciliochoroid in 7/28 cases (25.0%). Intraocular schwannoma was often clinically misdiagnosed as uveal melanoma, which occurred in 16/28 patients (57.1%). Tumour excision with pars plana vitrectomy was performed for all included patients. Endoresection with lens removal was performed for tumours in the choroid, while transscleral resection was performed for tumours located in ciliary body or ciliochoroid. Increased light transmission was detected in 12/28 cases (42.9%). In the consecutive follow-up (median: 73 months, range: 7–193 months), no cases of recurrence or metastatic disease were detected. Conclusions Intraocular schwannoma is a rare benign tumour. It usually presents as nonpigmented mass, which can easily be misdiagnosed as nonpigmented uveal melanoma.
- Open Access
- 23 November 2022
- Published by Springer Nature in Research Square
Vitreoretinal Amyloidosis: Clinical Features, OCT/A Insights, Gene Mutations, and Outcomes of Pars Plana Vitrectomy Surgery
Purpose: To describe the OCT/A findings, surgical findings and outcomes of vitrectomy among 8 eyes of 4 patients with vitreoretinal amyloidosis. Participants: Eight eyes of 4 Asian patients with a diagnosis of vitreoretinal amyloidosis from Jan 10, 2008, to Sep 10, 2021. Methods: Detailed history-taking, ocular and systemic examinations and genetic analysis of transthyretin mutation were performed. Vitreous biopsy, followed by 23- to 25-G pars plana vitrectomy was performed in all patients, and followed up on days 1, 7, and 30 and then, every 3 months. Results: The mean age at presentation was 45 years, with a 1:1 female-to-male distribution. The median follow-up was 85.3 (2-150) months. The OCT/A features of the vertical hyperreflective lesions appeared as punctate with moderate or high reflectivity, affecting all layers of the neuroretina in 7 eyes of 4 patients (7 of 8 eyes [87.5%]), and subtle needle-shaped patterns in 6 of 8 eyes (75%). Cotton-wool or waxy vitreous with firm vitreous adhesions beyond the major arcades and along the secondary retinal vessels was observed during vitrectomy in all eyes. The preoperative best-corrected visual acuity (BCVA) was ≤ 20/200 in 4 eyes (50%), whereas the postoperative BCVA improved to 20/100 to 20/25 in all eyes (100%). No patients subsequently were observed to develop systemic amyloidosis or dysfunction during follow-up examinations. Conclusions: The clinical clues, OCT/A features, surgical strategy, and vitrectomy outcomes in vitreoretinal amyloidosis were highlighted. We propose the term vitreoretinal amyloidosis instead of vitreous amyloidosis mainly based on the OCT/A features in this report.
- 23 November 2022
- Published by Springer Nature in Research Square
Open AccessVitreoretinal Amyloidosis: Clinical Features, OCT/A Insights, Gene Mutations, and Outcomes of Pars Plana Vitrectomy Surgery
Purpose: To describe the OCT/A findings, surgical findings and outcomes of vitrectomy among 8 eyes of 4 patients with vitreoretinal amyloidosis. Participants: Eight eyes of 4 Asian patients with a diagnosis of vitreoretinal amyloidosis from Jan 10, 2008, to Sep 10, 2021. Methods: Detailed history-taking, ocular and systemic examinations and genetic analysis of transthyretin mutation were performed. Vitreous biopsy, followed by 23- to 25-G pars plana vitrectomy was performed in all patients, and followed up on days 1, 7, and 30 and then, every 3 months. Results: The mean age at presentation was 45 years, with a 1:1 female-to-male distribution. The median follow-up was 85.3 (2-150) months. The OCT/A features of the vertical hyperreflective lesions appeared as punctate with moderate or high reflectivity, affecting all layers of the neuroretina in 7 eyes of 4 patients (7 of 8 eyes [87.5%]), and subtle needle-shaped patterns in 6 of 8 eyes (75%). Cotton-wool or waxy vitreous with firm vitreous adhesions beyond the major arcades and along the secondary retinal vessels was observed during vitrectomy in all eyes. The preoperative best-corrected visual acuity (BCVA) was ≤ 20/200 in 4 eyes (50%), whereas the postoperative BCVA improved to 20/100 to 20/25 in all eyes (100%). No patients subsequently were observed to develop systemic amyloidosis or dysfunction during follow-up examinations. Conclusions: The clinical clues, OCT/A features, surgical strategy, and vitrectomy outcomes in vitreoretinal amyloidosis were highlighted. We propose the term vitreoretinal amyloidosis instead of vitreous amyloidosis mainly based on the OCT/A features in this report.
- 1 July 2021
- Published by Springer Nature in Eye
- Vol. 36 (7) , 1448-1455
A proposed protocol of intravitreal injection of methotrexate for treatment of primary vitreoretinal lymphoma
Purpose Primary central nervous system lymphoma (PCNSL) is a non-Hodgkin lymphoma involving the brain with possible leptomeningeal and ocular involvement. This study aimed to evaluate the safety and efficacy of modified intravitreal injection regimen of methotrexate (MTX) for therapeutic management of vitreoretinal lymphoma. Materials and methods Forty human immunodeficiency virus (HIV)–negative Chinese patients with primary vitreoretinal lymphoma were included in this retrospective noncomparative interventional case series study. Patients were treated with a modified protocol of intravitreal injection of MTX (400 µg/0.1 ml) according to the Intensive-Consolidation-Maintenance regimen. The Intensive phase of once-weekly intravitreal injections for 1 month, followed by the Consolidation phase of one injection every 2 weeks for 1 month, and then the Maintenance phase of once monthly for 1 month, for a total of 7 injections. The primary main outcome measures were clinical response to intravitreal chemotherapy, number of injections for clinical remission, progression-free survival (PFS), overall survival (OS), visual acuity (VA), complications during the study period, and cause of death were investigated. Results The duration of follow-up from the commencement of injection of MTX was 12–73 months (median 28, 30.55 ± 14.73 months). A total of 61 eyes of 40 patients were cleared clinically from malignant cells after a median 6.57 ± 3.12 (median 6, range 1–14) times of injection of MTX. A second remission was induced in 3 patients, who were treated with a further course of intravitreal chemotherapy after tumour recurred in their eyes. The median PFS and OS were 20.82 months (95% CI 14.64–27.01) and 29.29 months (95% CI 16.16–42.41), respectively. Complications that occurred during the period of treatment and follow-up included corneal epitheliopathy (3 of 61 eyes) and cataract (6 of 61 eyes). There were no cases of maculopathy, vitreous haemorrhage, optic atrophy, and sterile endophthalmitis. No patient had an irreversible loss of vision that could be attributed to the intravitreal injection of MTX. Conclusions It can be concluded that the modified intravitreal injection regimen of MTX is an effective therapeutic approach in inducing clinical remission of intraocular involvement in PCNSL patients, associated with few complications. However, further study needs to be conducted to indicate whether the proposed approach extends life expectancy. Highlights Primary central nervous system lymphoma (PCNSL) can involve the vitreous and retina and is associated with a poor clinical outcome, with a survival rate of less than 3 months in absence of undergoing an effective therapeutic strategy. Methotrexate (MTX) is the most efficient cytotoxic drug for patients with vitreoretinal involvement in primary vitreoretinal lymphoma (PVRL), through intravitreal injection of MTX. In our experience, the modified protocol of intravitreal MTX according to the Intensive-Consolidation-Maintenance regimen, was effective in inducing clinical remission of PVRL with few complications. The accumulating clinical results brought us to propose the consideration of this protocol as a good first-line treatment option for PVRL.
- 1 July 2021
- Published by Springer Nature in Eye
- Vol. 36 (7) , 1448-1455
A proposed protocol of intravitreal injection of methotrexate for treatment of primary vitreoretinal lymphoma
Purpose Primary central nervous system lymphoma (PCNSL) is a non-Hodgkin lymphoma involving the brain with possible leptomeningeal and ocular involvement. This study aimed to evaluate the safety and efficacy of modified intravitreal injection regimen of methotrexate (MTX) for therapeutic management of vitreoretinal lymphoma. Materials and methods Forty human immunodeficiency virus (HIV)–negative Chinese patients with primary vitreoretinal lymphoma were included in this retrospective noncomparative interventional case series study. Patients were treated with a modified protocol of intravitreal injection of MTX (400 µg/0.1 ml) according to the Intensive-Consolidation-Maintenance regimen. The Intensive phase of once-weekly intravitreal injections for 1 month, followed by the Consolidation phase of one injection every 2 weeks for 1 month, and then the Maintenance phase of once monthly for 1 month, for a total of 7 injections. The primary main outcome measures were clinical response to intravitreal chemotherapy, number of injections for clinical remission, progression-free survival (PFS), overall survival (OS), visual acuity (VA), complications during the study period, and cause of death were investigated. Results The duration of follow-up from the commencement of injection of MTX was 12–73 months (median 28, 30.55 ± 14.73 months). A total of 61 eyes of 40 patients were cleared clinically from malignant cells after a median 6.57 ± 3.12 (median 6, range 1–14) times of injection of MTX. A second remission was induced in 3 patients, who were treated with a further course of intravitreal chemotherapy after tumour recurred in their eyes. The median PFS and OS were 20.82 months (95% CI 14.64–27.01) and 29.29 months (95% CI 16.16–42.41), respectively. Complications that occurred during the period of treatment and follow-up included corneal epitheliopathy (3 of 61 eyes) and cataract (6 of 61 eyes). There were no cases of maculopathy, vitreous haemorrhage, optic atrophy, and sterile endophthalmitis. No patient had an irreversible loss of vision that could be attributed to the intravitreal injection of MTX. Conclusions It can be concluded that the modified intravitreal injection regimen of MTX is an effective therapeutic approach in inducing clinical remission of intraocular involvement in PCNSL patients, associated with few complications. However, further study needs to be conducted to indicate whether the proposed approach extends life expectancy. Highlights Primary central nervous system lymphoma (PCNSL) can involve the vitreous and retina and is associated with a poor clinical outcome, with a survival rate of less than 3 months in absence of undergoing an effective therapeutic strategy. Methotrexate (MTX) is the most efficient cytotoxic drug for patients with vitreoretinal involvement in primary vitreoretinal lymphoma (PVRL), through intravitreal injection of MTX. In our experience, the modified protocol of intravitreal MTX according to the Intensive-Consolidation-Maintenance regimen, was effective in inducing clinical remission of PVRL with few complications. The accumulating clinical results brought us to propose the consideration of this protocol as a good first-line treatment option for PVRL.
- 7 January 2020
- Published by Springer Nature in Neuroradiology
- Vol. 62 (3) , 347-352
Using a novel MR imaging sign to differentiate retinal pigment epithelium from uveal melanoma
Retinal pigment epithelium (RPE) adenoma is a rare intraocular benign tumor. It is almost always misdiagnosed as uveal melanoma (UM) resulting in inappropriate management. The purpose of this study was to investigate MRI features of the RPE adenoma that may help differentiate this entity from UM.
- 7 January 2020
- Published by Springer Nature in Neuroradiology
- Vol. 62 (3) , 347-352
Using a novel MR imaging sign to differentiate retinal pigment epithelium from uveal melanoma
Retinal pigment epithelium (RPE) adenoma is a rare intraocular benign tumor. It is almost always misdiagnosed as uveal melanoma (UM) resulting in inappropriate management. The purpose of this study was to investigate MRI features of the RPE adenoma that may help differentiate this entity from UM.
- Open Access
- 18 August 2018
- Published by Press of International Journal of Ophthalmology (IJO Press) in International Journal of Ophthalmology
- Vol. 11 (8) , 1258-1268
Role of microRNA-21 in uveal melanoma cell invasion and metastasis by regulating p53 and its downstream protein
To reveal the insight mechanism of liver metastasis in uveal melanoma, we investigated cell functions of microRNA-21 in three different uveal melanoma cell lines and analyze the relationship of target gene p53 and its downstream targets. Quantitative reverse transcription polymerase chain reaction (qRT-PCR) was used to detect microRNA-21 expression in normal uveal tissue and uveal melanoma cell lines. Lenti-virus expression system was used to construct OCM-1, MuM-2B and M619 cell line with stable overexpression and inhibition of microRNA-21. In vitro cell function tests such as cell proliferation, cell apoptosis, cell circle and abilities of migration and invasion were examined by MTT, BrdU assay, flow cytometry, transwell assay and Matrigel invasion assay respectively. The target gene was predicted by bioinformatics and confirmed by using a dual luciferase reporter assay. The expression of p53 and its suspected downstream targets LIM and SH3 protein 1 (LASP1) and glutathione S transferase pi (GST-Pi) were determined by qRT-PCR in mRNA level and Western blotting analysis in protein level. Finally, the effect of microRNA-21 in a xenograft tumor model was assessed in four-week-old BALB/c nude mice. Compared to normal uveal melanoma, expressions of microRNA-21 were significantly higher in uveal melanoma cell lines. Overexpression of microRNA-21 promoted proliferation, migration, and invasion of OCM-1, M619 and MuM-2B cells, while inhibition of microRNA-21 reveal opposite effects. Wild type p53 was identified as a target gene of microRNA-21-3p, and proved by dual luciferase reporter assay. Up-regulated microRNA-21 inhibited the expression of wild type p53 gene, and the increased expression of LASP1 in mRNA level and protein level, while down-regulated microRNA-21 presented opposite way. However, GST-pi showed the potential pattern as expected, but relative mRNA level showed no statistically significant difference in OCM-1 cells. Furthermore, the mRNA expression of GST-pi was decreased in microRNA-21 overexpressing MuM-2B, and increased in M619 cells with inhibition of microRNA-21. In vivo, inhibition of microRNA-21 reduced tumor growth with statistically significant difference. These findings provide novel insight into molecular etiology of microRNA-21 in uveal melanoma cell lines, and suggest that microRNA-21 might be a potential candidate for the diagnosis and prognostic factor of human uveal melanoma.
- 18 August 2018
- Published by Press of International Journal of Ophthalmology (IJO Press) in International Journal of Ophthalmology
- Vol. 11 (8) , 1258-1268
Open AccessRole of microRNA-21 in uveal melanoma cell invasion and metastasis by regulating p53 and its downstream protein
To reveal the insight mechanism of liver metastasis in uveal melanoma, we investigated cell functions of microRNA-21 in three different uveal melanoma cell lines and analyze the relationship of target gene p53 and its downstream targets. Quantitative reverse transcription polymerase chain reaction (qRT-PCR) was used to detect microRNA-21 expression in normal uveal tissue and uveal melanoma cell lines. Lenti-virus expression system was used to construct OCM-1, MuM-2B and M619 cell line with stable overexpression and inhibition of microRNA-21. In vitro cell function tests such as cell proliferation, cell apoptosis, cell circle and abilities of migration and invasion were examined by MTT, BrdU assay, flow cytometry, transwell assay and Matrigel invasion assay respectively. The target gene was predicted by bioinformatics and confirmed by using a dual luciferase reporter assay. The expression of p53 and its suspected downstream targets LIM and SH3 protein 1 (LASP1) and glutathione S transferase pi (GST-Pi) were determined by qRT-PCR in mRNA level and Western blotting analysis in protein level. Finally, the effect of microRNA-21 in a xenograft tumor model was assessed in four-week-old BALB/c nude mice. Compared to normal uveal melanoma, expressions of microRNA-21 were significantly higher in uveal melanoma cell lines. Overexpression of microRNA-21 promoted proliferation, migration, and invasion of OCM-1, M619 and MuM-2B cells, while inhibition of microRNA-21 reveal opposite effects. Wild type p53 was identified as a target gene of microRNA-21-3p, and proved by dual luciferase reporter assay. Up-regulated microRNA-21 inhibited the expression of wild type p53 gene, and the increased expression of LASP1 in mRNA level and protein level, while down-regulated microRNA-21 presented opposite way. However, GST-pi showed the potential pattern as expected, but relative mRNA level showed no statistically significant difference in OCM-1 cells. Furthermore, the mRNA expression of GST-pi was decreased in microRNA-21 overexpressing MuM-2B, and increased in M619 cells with inhibition of microRNA-21. In vivo, inhibition of microRNA-21 reduced tumor growth with statistically significant difference. These findings provide novel insight into molecular etiology of microRNA-21 in uveal melanoma cell lines, and suggest that microRNA-21 might be a potential candidate for the diagnosis and prognostic factor of human uveal melanoma.
- 1 August 2018
- Published by Elsevier in Ultrasound in Medicine & Biology
- Vol. 44 (8) , 1703-1711
Non-Mass Breast Lesions on Ultrasound: Feature Exploration and Multimode Ultrasonic Diagnosis
- 1 August 2018
- Published by Elsevier in Ultrasound in Medicine & Biology
- Vol. 44 (8) , 1703-1711
Non-Mass Breast Lesions on Ultrasound: Feature Exploration and Multimode Ultrasonic Diagnosis
- 18 July 2010
- Published by BMJ in British Journal of Ophthalmology
- Vol. 95 (8) , 1072-1076
Retinoblastoma in the Beijing Tongren Hospital from 1957 to 2006: clinicopathological findings
Background To investigate the clinical and histopathological features of eyes enucleated due to retinoblastoma in a 50-year period in China. Methods The study included all eyes enucleated for retinoblastoma in the Beijing TongRen Hospital in the study period from 1957 to 2006. The clinical and histological charts, and histological slides were assessed for demographic and clinical data, and histological findings. Results The study included 1234 eyes. The mean age at the time of diagnosis (2.8±1.8 years) with a peak at 1 year of age decreased significantly (pConclusions In the last 50 years, the diagnosis of retinoblastoma in China has been improved markedly with a shorter delay in the diagnosis, an overall earlier diagnosis and a decrease in the clinical and histological stage at the time of treatment.
- 18 July 2010
- Published by BMJ in British Journal of Ophthalmology
- Vol. 95 (8) , 1072-1076
Retinoblastoma in the Beijing Tongren Hospital from 1957 to 2006: clinicopathological findings
Background To investigate the clinical and histopathological features of eyes enucleated due to retinoblastoma in a 50-year period in China. Methods The study included all eyes enucleated for retinoblastoma in the Beijing TongRen Hospital in the study period from 1957 to 2006. The clinical and histological charts, and histological slides were assessed for demographic and clinical data, and histological findings. Results The study included 1234 eyes. The mean age at the time of diagnosis (2.8±1.8 years) with a peak at 1 year of age decreased significantly (pConclusions In the last 50 years, the diagnosis of retinoblastoma in China has been improved markedly with a shorter delay in the diagnosis, an overall earlier diagnosis and a decrease in the clinical and histological stage at the time of treatment.
- 22 May 2010
- Published by Springer Nature in Graefe's Archive for Clinical and Experimental Ophthalmology
- Vol. 248 (11) , 1579-1585
Central corneal thickness, lamina cribrosa and peripapillary scleral histomorphometry in non-glaucomatous chinese eyes
To examine a potential correlation between a thin cornea, a thin lamina cribrosa and a thin peripapillary sclera in normal eyes of Chinese, as surrogate for a presumed association between a thin cornea and an increased glaucoma susceptibility.
- 22 May 2010
- Published by Springer Nature in Graefe's Archive for Clinical and Experimental Ophthalmology
- Vol. 248 (11) , 1579-1585
Central corneal thickness, lamina cribrosa and peripapillary scleral histomorphometry in non-glaucomatous chinese eyes
To examine a potential correlation between a thin cornea, a thin lamina cribrosa and a thin peripapillary sclera in normal eyes of Chinese, as surrogate for a presumed association between a thin cornea and an increased glaucoma susceptibility.